AARST Mourns the Loss of Matt Ellefson
Researchers will use IASLC/LCFA funds to create new lung cancer treatments for never-smokers and patients whose cancer has spread
Dartmouth Start Up Poised to Disrupt Radiation Therapy Verification
MyCancerJourney empowers patients with actionable information to improve the patient's experience and outcomes in cancer treatment.
Sept. 26 event will benefit UW Carbone Cancer Center
Building a new Network of 19 Independent Practices Across 17 States
Through non-profit crowdfunding, 2redWinery rewards supporters with award-winning wines to fund prostate cancer research.
C-Dose™ captures Cherenkov emissions for a novel look at Radiotherapy in action
CogniFit research team has developed a digital neuropsychological test designed to help screen cognitive difficulties in cancer patients who are experiencing the mental fog known as chemo brain
Planet TV Studios produces cutting-edge, real-life, television series that feature insightful, meaningful updates on the most important business, medical and social responsible topics currently taking place in the areas most important to our lives.
After 10 years of service in Santa Barbara County, Organic Soup Kitchen launches new venture for cancer recovery hub.
One of America's foremost oncologists leads this webinar series on the past, the present and the future of immunotherapy studies
Funding aimed at combination therapies that increase the effectiveness of immunotherapy
Flow cytometry provides a highly adaptable and quantitative method for investigating both the cellular distribution and intracellular changes that occur in tumors and peripheral lymphoid organs in response to therapy.
Funds will go toward the American Society of Clinical Oncologists Young Investigator Award
A Network of 19 Independent Practices Across 17 States
Presented by Covance Chief Scientific Officer Steve Anderson, Ph.D., and Covance Global Leader, Precision Medicine and Head, Biomarker Solution Center, Suso Platero, Ph.D., this webinar will address the spectrum of immunotherapy development considerations and their implications for drug developers.
Dartmouth scientists found a therapeutic approach that should prevent the development of resistance to targeted anti-tumor drugs in gliomas